Conclusions: ALK IHC-positivity in ALK-rearranged lung AdCA is clone dependent. The majority (60%) of laboratories utilized the ALK1 clone, despite known insensitivity of this clone in this setting. Clone 5A4 performed much more poorly than in published literature, suggesting challenges in antibody optimization. D5F3 performed well. These results highlight the importance of antibody selection, optimization, and clinical validation for predictive marker IHC testing.
Design: All respiratory virus BFAs run at our institution between August 2014 and July 2015 were collected; 510 results were identified. Patient location (ED, in/outpatient), virus positivity, and virus type were recorded. Data analysis was performed in Microsoft Excel. Results: Of 510 patient samples, 188 were positive for a viral pathogen (36.9%). The most common viruses were rhino/enterovirus (RV/EV; not separable on this assay), IVA/B, and respiratory syncytial virus (RSV; Figure 1 ). At their peak, IVA/B represented 25.2% of total samples (55% of total positives; January). The cost comparison of first line BFA versus IVA/B single PCR followed by second line BFA in IVA/B negative cases is shown in Table 1 . Figure 1 : Frequency of Viruses Detected by BFA
Conclusions:
A viral etiology was common for URI symptoms (36.9% of tested patients, Figure 1 ). First line use of the BFA was more cost effective than screening via IVA/B single PCR; this relationship inverts if IVA/B positives represent >29% of total samples, or if <71% of total samples undergo BFA (such as restricting BFA only to admitted IVA/B negative patients, as at our institution). In any case, even limited use of the BFA provides epidemiological data with potential utility both for research and infection control purposes. Background: Cerebrospinal Fluid (CSF) evaluation plays an increasing role in the diagnosis and staging of patients with hematopoietic neoplasms. The evaluation is based on the morphological evaluation of the specimen and flow cytometry studies (FC). FC is known to be more sensitive than cytology, but it can identify small clonal proliferations of unknown clinical significance. The impact of the increased sensitivity of FC and its correlation with the morphological analysis of CSF needs to be evaluated to better guide clinical management. Design: We retrospectively identified 356 CSF specimens sent for FC, cytology and cell count between March 2014 and December 2014, of which 79 from 45 different patients had discordant results. Seventy-four specimens had cytology specimens (ThinPrep, pap stained slides), FC specimens and slides used for cell count (Cytospin, air dried Giemsa stained slides) available for review. Each preparation was interpreted independent of the FC results as negative or abnormal. An extensive review of each patient's medical record was performed.
Cerebrospinal Fluid Specimen Evaluation in Patients with

Results:
The sensitivity of each of the specimens are described in Figure 1 .
Alcohol fixed ThinPrep slides had the lowest sensitivity. Review of the Giemsa stained slides used for cell count increased the sensitivity of the morphological evaluation to 82.9%. Six patients who did not receive treatment based on initial negative morphological results were later found to have CSF involvement. Inability to initially corroborate the FC diagnosis resulted in four patients not being treated and two undergoing surgery for definitive diagnosis of diffuse large B-cell lymphoma. Incorporation of the Giemsa stained slides would have provided corroboration in three of the six cases. Conclusions: ThinPrep slides had the lowest sensitivity, probably due to its larger screening areas combined with alcohol fixation. Accurate diagnosis of CSF specimens from patients with hematopoietic disease require integration of morphological findings from both alcohol fixed, Giemsa stained slides and flow cytometry results.
Quality of Reporting in Predictive Biomarker Studies in Anatomic Pathology Journals
Justin Caron, Michael B Cohen, Robert L Schmidt. University of Utah School of Medicine, Salt Lake City, UT. Background: Studies on predictive biomarkers are frequently published in pathology journals. Such prognostic studies are complex, and guidelines have been published that outline the data that should be reported by each study to enable readers to evaluate the quality of the research. Complete reporting is also critical for the production of high-quality systematic reviews and meta-analyses. Reporting guidelines have not been widely adopted by pathology journals. Journals in other disciplines often require authors to submit checklists to ensure adherence to reporting guidelines; however, this is uncommon in pathology. This study evaluated the quality of reporting of prognostic studies published in pathology journals.
Design:
We identified all prognostic studies published in the American Journal of Clinical Pathology, the American Journal of Surgical Pathology, and Modern Pathology published between January and August 2015. We randomly selected ten studies from each journal. We evaluated each study using the REMARK reporting guidelines for prognostic studies. A scoring statistic was created based on the elements in the REMARK guideline. Adherence was expressed as percent items reported. REMARK items with multiple components were scored by component and averaged to obtain an item score. Each study was independently scored by two referees. Disagreements were resolved by discussion for items that had less than 80% concordance.
Results:
The initial inter-rater agreement was 71%. Agreement increased to 95% following discussion and rescoring of items with low (i.e., less than 80%) agreement. On average, authors reported 51% of the items listed in the REMARK guideline. There was no significant difference between journals. The following items were poorly reported: power analysis (reporting frequency = 3%), flow diagrams (4%) or REMARK profiles (0%), correlations between predictors (3%), or model validation or assumption checking (2%). No study described methods for handling missing values or reported results of missing value analysis. Only one study divided data into a training set and validation set. None of the studies included all of the required information.
Conclusions:
Authors of prognostic studies fail to report the items recommended by the REMARK guideline. The absence of this information significantly limits the value of these studies as evidence for inclusion in systematic reviews, meta-analyses, costeffectiveness analysis, and practice guidelines. Background: High quality research biospecimens are key elements of success towards developing truly personalized medicine of the future. Research biopsies are being increasingly used to obtain tissue from patients with cancer, either when no surgical resection has been performed, or to monitor response to therapy. We report on the histological quality of research biopsies banked with our program towards determining their suitability for subsequent molecular analysis. Design: Research biopsies were obtained under institutionally approved research protocols from consented patients with either localized prostate cancer (pre and post radiotherapy), advanced melanoma, or with pancreatic cancer liver metastases. Up to 12 cores were obtained per patient. Cores were immediately snap frozen in OCT, fixed, and embedded in paraffin, or transferred fresh into culture medium for xenografting into NOD SKID mice. Reviews were performed on H&E slides from fixed and frozen tissue blocks.
Results: H&Es of 99 cores from 33 patients were reviewed. Most of the cores (59/99) were positive for malignancy: 34/65 prostate cancer, 21/26 melanoma and 4/8 pancreatic cancer liver metastases cores contained tumor, ranging from 90% to less than 5% of represented tissue. Although patient-derived murine xenografts were successfully established in all 5 cases of pancreatic cancer liver metastases from fresh cores taken at the same time, only 1/5 cases (and 1/8 cores) had sufficient tumor cellularity for DNA and RNA extraction for whole genome and RNA sequencing. Research biopsies from 8 patients were completely negative for malignancy: 15 cores from 3 patients with prostate cancer, 5 cores from 3 patients with advanced melanoma localized to the arm, lymph node and lung, and all 3 cores from 2 cases of pancreatic cancer liver metastases. Conclusions: Pathology review of research biopsies banked with our program has demonstrated variability in quality between patients with diverse and similar cancer types, as well as between cores from the same patient. The results highlight the importance of assessing tumor cellularity and histological quality prior to downstream analysis. Through close monitoring of preanalytical variables such as disease type, tissue site, and patient pretreatment and tracking downstream results such as histological quality, integrity of molecular analytes such as DNA and RNA, and maintenance of cell viability through patient-derived xenografts, it may be possible to identify ways to optimize the utility of these important next generation biospecimens.
Evaluating Pathologist Accuracy in Estimation of Percentage of Malignant Cells
Hui Chen, Russell Broaddus, Bedia A Barkoh, Ronald Abraham, Rajesh Singh, Raja Luthra, Sinchita Roy Chowdhuri. MD Anderson, Houston, TX. Background: Accurate estimation of invasive tumor fraction in solid tumors submitted for molecular testing is a critical variable for testing success. The interpretation of comprehensive and advanced diagnostic genomic tests such as next-generation sequencing (NGS) and SNP microarray requires the precise estimate of tumor fraction to avoid false-negative test results. Prior studies based on the College of American Pathologists Survey have shown low inter-laboratory precision among pathologists using visual estimation for determining tumor fraction. To minimize variability in tumor fraction estimation, our division has initiated a quality improvement project since 2013 by designating a tissue qualification laboratory (TQL) staffed with dedicated pathologists with experience in molecular diagnostics to select tissue sections and to evaluate tumor fraction for molecular testing. , We retrospectively reviewed core needle biopsy (CNB) samples to determine visual estimation accuracy among TQL pathologists. Design: We evaluated 121 consecutive malignant CNBs performed by interventional radiologists, 2013-2014. Tumor enrichment was performed by selecting and circling areas within the tissue section by TQL pathologist 1. Each case was evaluated independently by at least 1 other TQL pathologist and a subset of cases were reviewed by a third TQL pathologist. The discordant slides were reviewed together at the end of the study. NGS was performed on 22 cases using the Ampliseq Cancer Hotspot v2 panel on the Ion Torrent PGM (Life Technologies, CA). Variant frequency was recorded and normalized with the tumor fraction estimate.
Results:
The tumor fractions ranged from <10% to 90% (median 40%, mean 41%). The tumor fraction estimate between TQL pathologists 1 and 2 showed excellent concordance with identical results in 59 cases (49%) and <10% difference in 61 cases (50%), with a single case (<1%) showing >10% difference. Variant frequency obtained from NGS analysis is an alternative, though imprecise, method for estimation of tumor fraction. Using the variant frequency as a rough estimate of the tumor content of the specimen, the averaged tumor fraction estimates of the 3 TQL pathologists were within 10% of the adjusted variant frequency in 13 cases (59%) and between 11-15% in 8 cases (36%), with a single case at 23% (4%). Conclusions: Our findings suggests that visual estimation of tumor fraction by TQL pathologists is fairly accurate and that significant estimation errors can be avoided when using dedicated and experienced pathologists for molecular qualification of solid tumors. 
Background:
The dashboard format of quality metric monitoring has been widely accepted as the industry standard for real-time data representation and monitoring. Although laboratories track numerous quality metrics, indicator data are often collected and reviewed using outdated and manual techniques. Standardized quality data reporting templates do not exist, making data difficult to interpret and timely improvement efforts challenging. We chose to transform our process, adopting a real-time digital Quality Dashboard (QD). Design: A multidisciplinary team was assembled composed of the Quality Medical Director, a Process Improvement Specialist, the Laboratory Operations Director, and Safety and Compliance officers (3). Team goals included a full review and update of quality metrics with a focus on patient care and clinician experience, as well as subsequent monitoring of established targets for improvement efforts. A standardized data collection template was designed and utilized by lab managers for uniform input of electronic performance data. Using formulas embedded into the template design, graphics such as run charts, control charts, and percentage charts were automatically generated and inserted into the QD. A simple visual red/green color-coded trigger system, based on the Toyota Production System "andon", was used to monitor real-time performance and cue targeted improvement efforts.
Results:
The QD format was rolled out in March 2015 and has been reviewed by lab managers and medical directors on a bi-monthly basis. 11 of 14 lab divisions have modified their quality and performance indicators based on the QD, shifting their focus from quality targets that had already been achieved to those in need of improvement. Red/green "andon" triggers have allowed rapid visual performance feedback and have given rise to 12 quality improvement projects in anatomic pathology (5), hematology (2), clinical chemistry (1), blood bank (2), autopsy (1) and microbiology (1). Statistical control charts have determined process reliability and highlighted irregular workflows in need of redesign. Since the QD rollout, quality data review has been transformed from a cursory and frustrating process to a timely and proactive culture of continuous improvement.
Conclusions:
Outdated narrative and manual data collection, analysis, and presentation methods impede the effectiveness and timeliness of quality management. Creation of a comprehensive digital QD enabled us to monitor overall laboratory performance in real-time, and served as a guide for quality and process improvement activities. shown to one of 8 attending pathologists, with each pathologist interpreting the same cases that they had originally interpreted at the time of the frozen section. At the time of interpretation, the pathologists had access to the clinical history as written in the original requisition sheet provided with the specimen. The pathologists received no prior formal training or practice before interpretation of the WSI. In addition, one fellow reviewed all of the cases to estimate the degree of interobserver variability. Results: Of the 62 slides that were initially scanned, 7 cases were excluded for the following reasons: 2 were out of focus on the WSI, 2 cases had folded tissue that precluded interpretation, 3 cases were lost in the data archives prior to interpretation. Of the 55 cases that were interpreted, the diagnosis rendered using the virtual slide was concordant in 50 (91%) when compared with the original intraoperatively rendered diagnosis. Major discordance was seen in 3 cases (5%) and minor discordance was seen in 2 cases (4%). Kappa was estimated to be 0.79. The interobserver concordance was found to be 95% (kappa 0.89).
This preliminary validation show that the intraobserver variability for pathologists at our institution when using virtual slides is comparable to that seen by other authors. Our findings suggest that WSI may be an effect tool to provide remote secondary consultation support during intraoperative frozen sections. The proper handling of unstained cut paraffin slides has been a matter of debate, with several studies demonstrating loss of antigenicity with prolonged storage at -20 °C and/or room temperature. In particular, stored slides have shown significant loss of Human epidermal growth factor receptor 2 (HER2) staining after storage at room temperature for 6 months. The purpose of this study was to determine if long term storage of unstained slides at -80 °C would impact the staining intensity and expression distribution of cytokeratin 5 (CK5), epidermal growth factor receptor (EGFR), Ki67, estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2).
Design:
The staining pattern of invasive ductal breast carcinoma slides (n=34-64) stored at -80 °C for at least 10 years was compared to the staining pattern of fresh cut slides. The Allred scoring method was used to score ER (0,2=negative, 3-8=positive), CK5 (≥4=positive) and EGFR (≥4=positive). ASCO/CAP guidelines were used to assess HER2 (0/1+, 2+ or 3+). Ki67 positive tumor cells were determined based on the proportion of cells stained of any intensity, with 14% staining used as a cut-off. Agreement was assessed using concordance rates and chance corrected agreement statistics.
Results:
The concordance between stored and fresh cut slides for ER, CK5, EGFR and HER2 was high with chance-corrected agreements of 0.94, 0.92, 0.87 and 0.86 respectively. The chance-corrected agreement for Ki67, however, was 0.51. For Ki67, nine tumors were called low on stored slides but high on fresh cut slides, and one tumor was called high on stored slides but low on fresh cut slides. Conclusions: Long term storage of cut unstained slides at -80 °C does not significantly impact the scoring interpretation of ER, CK5, EGFR and HER2. Background: Immunohistochemistry (IHC) has been variably used, with hematoxylineosin staining (H&E), to facilitate detection of small melanoma deposits in lymph nodes. However, IHC increases costs and demands on laboratory resources. This study assessed the utility of upfront IHC as a component of the standard protocol for evaluation of sentinel lymph nodes (SLNs) from patients with malignant melanoma (MM). Design: Multiple institutions in the USA and Canada were electronically surveyed to obtain information about their protocols for evaluation of SLNs excised for possible metastasis of MM. The pathology database at our medical center was searched for all SLN excisions performed on patients with MM from October, 2013 through June, 2015. All available H&E, S100, HMB-45, and Melan-A slides from these cases were re-examined. Metastases were classified as macrometastasis (>2.0 mm), micrometastasis (0.2-2.0 mm) or isolated tumor cells (ITCs, <0.2 mm).
Results: Fourteen institutions provided information about their standard protocols. Ten (including our institution) order IHC upfront (before H&E review) and four order IHC only if an H&E appears negative or suspicious for metastasis. 340 SLNs submitted in 494 tissue blocks from 150 consecutive patients (median age: 61 years; range 23-94 years) with MM were evaluated, revealing 21 (associated 37 blocks; 7.5%) that were positive on H&E (6.2%), showing macrometastasis (n=10), micrometastasis (n=9), and ITCs (n=2). S100, Melan-A, and/or HMB-45 identified an additional 9 (associated 14 blocks) positive SLNs (2.6%), which included micrometastases (n=3) and ITCs (n=6) that were not recognized on initial H&E review. what is understood by its readers. This study compared perceived diagnostic certainty between pathology attendings, residents and clinicians through common diagnostic phrases and scenarios. Design: Anonymous surveys were completed by 4 practicing pathology attendings, 10 pathology residents, 18 attending clinicians and 16 resident clinicians. All participants rated % certainty associated with 7 diagnostic terms: "diagnostic of", "consistent with", "we favor", "suggestive of", "suspicious for", "compatible with" and "we cannot rule out". Pathologists answered 2 qualitative questions related to utility of immunohistochemistry (IHC) and the diagnostic comment. Clinicians answered additional questions regarding utility of other communication methods (tumor boards/ conferences, phone calls, email, text message) in clarifying diagnoses and how often the diagnostic comment is read.
Results: A wide range in % certainty was found for each of the 7 diagnostic phrases. "Diagnostic of" conveyed the best agreement as to % certainty, while % certainty for "compatible with" ranged from 10% to 90%. There was a lack of consensus between pathologists regarding the impact of unavailable or contradictory IHC results. While 75% of attending pathologists and 60% of pathology residents believe the diagnostic comment clarifies the diagnosis "very well", only 72% of attending and 50% of resident clinicians "always" read the comment section, and 28% of attending clinicians and 50% of resident clinicians "sometimes" read the comment.
Conclusions:
The understood level of certainty for diagnostic phrases varies widely amongst pathology attendings, pathology residents and clinicians. This may impact pathology training as trainees navigate which phrases to use and in what context. Efforts to standardize use of diagnostic terms may improve communication. Clinicians regard tumor board/conferences, face to face meetings and phone calls as best ways to clarify a diagnosis. While pathologists often rely on the diagnostic comment to clarify uncertainty, a significant number of clinicians do not regularly read the comment. Follow-up biopsies were performed in 422 cases. Negative Pap tests with HGCL on biopsy were randomized with equal numbers of random cases from the study period for review by two cytopathologists blinded to the study. Results: In this cytology negative cohort, HGCLs were identified in 22 (5.2%) of 422 biopsies with hrHPV positive in 20 (91%) and negative in 2 (9%). The HGCLs included 20 high grade squamous intraepithelial lesions (HSIL), 1 adenocarcinoma in situ and 1 squamous cell carcinoma. Positive hrHPV test was strongly associated with HGCL on biopsy (p<.001) with a high sensitivity (91%) and negative predictive value (NPV, 99%), but low specificity (45%) and positive predictive value (PPV, 8%). Upon review of the available 21/22 NILM Paps, 9 (43%) were upgraded to ASCUS or higher, including 3 (14%) HSIL or ASC-H. All upgraded cases were hrHPV positive. Discrepancies for minor lesions were observed between reviewers in two cases. The contributing factors for negative Pap tests were lack of abnormal cells (10/21, 48%), low grade cells not diagnostic for HGCL (6/21, 28%), unsatisfactory sample (2/21, 10%), and interpretation variances due to marked inflammation (3/21, 14%).
HPV Status and Other Contributing Factors to Negative Pap Tests in Women with Biopsy Proven High Grade Cervical Lesions
Conclusions:
Negative Pap tests were identified in 5.2% of women with HGCL on follow-up biopsy in this low risk population. Although hrHPV was detected in most of the HGCL cases, its specificity for HGCL was low (45%). As many as 92% of the hrHPV-positive cases were negative for HGCL on biopsy, resulting in a low positive predictive value (PPV) for HGCL by either hrHPV test (8%) or HPV 16/18 genotyping (11%). The most common reason for negative Pap tests in women with biopsy-confirmed HGCL was absence of diagnostic cells (86%), presumably due to sampling variance. Obscuring inflammation was the main contributing factor for interpretation variance. Negative Pap tests with marked inflammation and positive hrHPV may warrant rescreening to minimize the false-negative rate. Background: High reliability practices are significantly associated with improved quality and patient safety in a variety of healthcare settings. For example, timeouts (team huddles) at the start of surgical procedures is a high reliability practice that, because of its positive impact on patient safety, has become the standard of care. This study describes the implementation and impact of such a team huddle in surgical pathology as part of systematic effort to expand high reliability practices and improve safety culture across the anatomic pathology lab of a tertiary academic medical center. Design: Results of a standardized patient culture survey along with additional systematic collected data and gap analyses were used to develop specific and focused quality improvement (QI) projects. This included implementation of a daily surgical pathology huddle. The impact of this on different quality metrics, safety culture and team engagement was assessed.
Results:
The entire gross room/frozen section (FS) team for day participates in the huddle, including pathology technologists, pathologists' assistants, residents rotating in surgical pathology, the surgical pathology fellow and attending pathologist. Main items that are communicated in this approximately 5 min briefing/debriefing session are highlights of the operating room schedule including predicted intraoperative consultations, key volume metrics for the previous day, staffing coverage, expected slide delivery times from histology and debriefing of previous day work issues. For continuous improvement, a survey was performed that indicated that most participants thought that the huddle provides up-to-date, easy-to-follow information, addresses relevant questions, clarifies issues and helps better prepare for the day. The impact of this huddle and implementation of other associated high reliability practices included (1) reduction of major FS discrepancy rates, (2) reduction of single and multiple FS TAT, (3) increased number of QI projects across the lab, (4) increased engagement at all levels and (5) improvement in the saftey culture. The latter was manifested by improvements in 9 of 12 safety dimensions measured in a repeat survey, including a 5% improvement in the overall perception of safety. Conclusions: Huddles in surgical pathology provide a constructive, blame-free environment for respectful personal interaction that allows for dissemination of information and brief discussion, create a nidus for generating additional improvements and result in improved outcomes and increased engagement and mindfulness of the entire team.
Implemenation of a "Lean" Cytopathology Service -Towards Routine Same-Day Reporting
Ekkehard Hewer, Anja M Schmitt. University of Bern, Bern, Switzerland. Background: Lean management has gained popularity for design of faster and safer processes in health care. A continuous workflow as opposed to processing of large batches of specimens is central in lean management and makes it particularly suitable for cytopathology. Nevertheless, only few studies adress the effect of lean management principles with respect to organiaziation of diagnostic cytopathology units. Design: We applied lean management principles to reorganize our diagnostic cytopathology service. Changes included introduction of a continuous workflow (facilitated by modernization of key devices) and a structured electronic reporting system. We monitored the effects of these changes on turnaround times. Results: Introduction of a fully "lean" workflow for cervical cytology increased the percentage of specimens reported within one week from 65% to 97%. 63% of cervical cytology specimens were reported within one working day as opposed to 6% at baseline.
Continuous processing of non-gynecological specimens alone (without changing the reporting process) resulted in 18% and 77% of cases being reported on the same day or within one working day, respectively (3% and 55% pre-Lean).
Conclusions: Stringent application of Lean Management principles allows for significant reductions in turnaround-times. It may therefore contribute to routine sameday reporting of cytological specimens. The pathology database of our institution was searched for cases in which an IGE for colorectal resection was performed and filtered based on whether an extra specimen was received that could have been due to the findings reported. Operative notes were reviewed to determine whether the extra specimen was due to the IGE. Results: 200 cases over a 14 month time-frame were reviewed. 21 different final diagnoses were rendered. The 3 most common accounted for 78% of cases; adenocarcinoma (95), IBD (42), and diverticular disease (19). 14 surgeons requested IGE with the top 6 accounting for 91% of cases. After thorough review of the operative notes, none of the 200 IGE cases had additional tissue resected as a direct result of the IGE findings. Additionally, we found no statistically significant difference in the distance to closest margin when comparing IGE to a set of control cases with no intraoperative consultation.
Conclusions:
Surgeons request IPCs for many reasons including necessity for immediate management, research interests, and providing patients immediate results. However, IPCs should only be used when results will immediately alter surgical management. Our study showed that no additional surgical management was undertaken given the results from IGE. The most applicable use of IGE is margin status evaluation, and the most recent NCI guidelines recommend five cm of clearance. Extra margins were not received for the cases with less than five cm of clearance and no difference was observed when comparing to control cases with no IPC. As we continue to battle rising health care expenses, ways to reduce costs will be crucial. Decreasing unnecessary intraoperative consultations may represent a cost and resource saving measure in surgical pathology.
Is Digital Imaging a Viable Method of Measurement for Breslow Thickness in Invasive Melanomas? An Example of Evaluation of Uncertainty in a Critical Value in Cellular Pathology
Yi Ling Khaw, Barbara Loftus. Tallaght Hospital, Dublin, Ireland. Background: In cellular pathology, the assessment of the uncertainty of measurement (UoM) is an unfamiliar area of quality assurance. The Royal College of Pathologists UK (RCPath) issued a set of guidelines in May 2015 to outline the most appropriate ways to meet this aspect of the ISO 15189 standard. Breslow thickness (BT) is a critical value which determines stage, prognosis and plays a major role in patient management. Therefore it is appropriate to consider the uncertainty of its measurement.
In this study, we also determine if Digital Imaging (DI) is a viable alternative modality of measurement in addition to the Vernier Scale (VS). Design: OBJECTIVES: (i) To measure precision / UoM. (ii) To determine if DI is a viable alternative to the VS (intermodality variability). (iii) To determine baseline interobserver and intraobserver variability for future audits. METHOD: Glass slides for 50 cases of cutaneous invasive melanoma were examined. BT was re-measured by the Reviewer using both modalities VS and DI. These values were compared with the Reported BT values.
Results:
The mean variation was 0.078mm and this value is taken to represent overall precision. In our opinion, this value is chosen to best represent UoM. Interobserver, intraobserver and intermodality variations (each of the three groups) were not statistically significant. When the DI and VS (intermodality variation) were compared, the resulting measurements were extremely precise with a difference of only 0.064mm. This value has been used as a surrogate marker for intraobserver variation and thus reflects good intraobserver reproducibility.
Conclusions:
Measurements with both DI and VS are both precise and very reproducible. We conclude that DI is a more useful when a second decimal point is mandatory in situations when it is likely to change the pT stage ie. at the pT stage boundaries. DI should be recommended for use as per personal preference. The estimated uncertainty of measurement is small 0.078mm. This value will be used in future audits. In order to minimise intra-and interobserver variation, standard operating procedure (SOP) for the process of measuring BT will be created.
Quality Assurance of Anatomic Pathology Diagnoses: Comparison of Alternate Approaches and Detection of Diagnostic Error
Lester Layfield. University of Missouri, Columbia, MO. Background: Traditionally, a 10% review has been the basis for quality assurance programs in anatomic pathology. The effectiveness of such a protocol has been questioned and alternative methodologies suggested. Little published data exists comparing yield for detection of diagnostic errors by alternate strategies. Design: The detection rate for diagnostic errors in surgical pathology was compared over a three-month period using different review procedures comprising: random 10% review, correlation of internal and external diagnoses following solicited external expert opinion, a focused review of dermatopathology cases and correlation of internal diagnoses with outside diagnoses in cases sent for review at a second institution treating the patient. Error rate was expressed as percentage of reviewed cases where the initial diagnosis differed from the review diagnosis. Error rates detected by each method were compared between the methods. Results: The 10% random review detected six errors in 597 cases (1%). Solicited case consultations requested by clinicians or internal pathologists detected two diagnostic errors in 16 cases (12.5%). Unsolicited reviews by outside institutions in course of patient care detected one diagnostic error in 46 cases (2%). Review of the dermatopathology material disclosed 5 diagnostic errors in 59 cases (8.5%).
Conclusions:
The alternate review procedures have different biases which appear to result in different frequencies of detected error. The 10% random review includes larger numbers of routine cases (appendectomies, etc.) where there is little chance for diagnostic error. The other methodologies are more likely to review diagnostically problematic cases associated with a greater number of errors. Cases referred to expert consultants for diagnostic concerns would be expected to have the highest rate of error as demonstrated in the present study (12.5%). Cases sent for review associated with treatment at a second institution represent therapeutically important specimens but are less likely to be selected due to questions concerning the original diagnosis. Focused reviews initiated by diagnostic concerns of a clinician or pathologist, unsolicited reviews because of treatment at another institution and sub-specialty based reviews appear to be more effective in detecting diagnostic errors than the standard 10% random review. Quality assurance programs should include focused reviews in addition to 10% random review to maximize error detection.
Ancillary Testing in Bone Marrow
Background: A diagnosis of lymphoma is typically followed by bone marrow staging with associated ordering of extensive ancillary testing at the time of procedure. This practice presents a utilization management challenge since morphology in conjunction with limited immunophenotyping remains the diagnostic benchmark. We hypothesize the majority of such testing is noncontributory to patient management and represents an opportunity for cost savings without impact on the quality of care. Design: We conducted a search of our information system for all adult bone marrow samples submitted to our laboratory in the past 5 years with a specified indication of initial lymphoma staging. This yielded a total of 227 patients (M:F ratio, 1.3; age range, 20-90; median, 58 years). Pathology reports were reviewed and data extracted including primary diagnosis, staging result and status of ancillary studies. Cost analysis was performed using a test-specific 12-month average price history. Results: :
Conclusions:
The diagnostic performance of morphologic evaluation in the context of lymphoma staging is high and when combined with flow cytometry, sensitivity exceeds 98%. Genetic studies (karyotype and FISH) are highly specific when lymphomaassociated abnormalities are found, but demonstrate low yield while contributing significant cost. We noted only one instance of a positive karyotype finding in the absence of morphologic and immunophenotypic evidence of lymphoma. These data support implementation of a decision tree approach to ancillary testing which begins with morphology followed by limited immunophenotyping (by flow cytometry or IHC). Genetic studies should be deferred (culture, nucleic acid extraction and hold) and can be performed subsequently if indicated. The mean cost per marrow is $851 given observed utilization. Conservative modeling suggests at least $305 per specimen could be saved by implementing a stepwise testing strategy.
Evaluating the Immunostaining Detection of Cytomegalovirus in Gastrointestinal Biopsies: Clinical Pathological Correlation
Xiaoyan Liao, Grace Y Lin. UCSD, San Diego, CA. Background: Cytomegalovirus (CMV) infection is ubiquitous and can be subclinial and asymptomatic. At our institution, immunostain for CMV is ordered if clinically warranted and ulceration present. We aim to study the clinical-pathological correlation of CMV immunostaining detection in gastrointestinal (GI) biopsies to provide a practical guideline for better management. Design: Pathology information system was electronically searched, and 935 out of 7421 total non-neoplastic GI biopsies (12.5%) were tested for CMV between 1/1/2013 -6/30/2015. Ninety-one (1%) cases reported positive stains and were re-evaluated microscopically. The results are classified as "positive" if >2 cells are stained (n=49), or "rare positive" if 1-2 cells are stained (n=42). Of these 91 cases, pre-existing conditions include inflammatory bowel disease (IBD, n=34), HIV infection or AIDS (n=15), and other immunocompromised conditions including solid organ or bone marrow transplant (n=42). Clinical information (virology tests and specific treatment) and follow-up biopsies are reviewed. Statistical analysis is performed using SPSS.
Results: Overall 1% of GI biopsies show immunostaining for CMV. The more tests ordered, the smaller percentage of cases were detected. Viral cytopathic effect is specific but not sensitive as only 9 (10%) cases were reported. Clinician's request to rule out CMV infection yields higher detection rate (43/118, 36%) than overall (91/935, 9.7%).
The most commonly involved organ is colon, followed by esophagus, stomach, ileum and duodenum. When >2 cells are detected, CMV virology is positive in 55%, negative in 16%, not tested in 28% of cases. When only 1-2 cells are detected, CMV virology is positive in 24%, negative in 24%, not tested in 52% of cases. The difference is statistically significant by Fisher's exact test (p<0.01). Follow-up biopsies in CMV "rare positive" patients are frequently negative, and only 31% of those patients are treated comparing to 71% treated in CMV "positive, >2 cells" patients (Chi-square=14.8, 
Osteomyelitis and Lower Extremity Amputations at a Single
Institution: A Quality Assurance Study Valerie Lockhart, Erin E Langford, Guillermo A Herrera. LSU Health Shreveport, Shreveport, LA.
Background:
The diagnosis and treatment of osteomyelitis (OM) requires a multidisciplinary approach. Establishing an accurate diagnosis of OM is imperative, since treatment with prolonged antibiotic therapy and/or aggressive surgical intervention is necessary. Bone biopsy, the gold standard for diagnosing OM, is rarely done. X-ray and MRI are the imaging modalities of choice for diagnosis of OM. Without pathologic confirmation of suspected OM, radiologists/surgeons will lack quality assurance information with which to improve patient care. Design: 437 lower extremity amputations received at our institution from 2011-2015 were identified in Co-Path. EPIC records were reviewed to identify pre-amputation clinical/radiologic suspicion for OM, and 67 cases were found. The cases were stratified into two groups based on radiology and pathology reports: incomplete and complete evaluation for OM. Incomplete evaluation was subclassified into bone submitted (but not reported on final diagnosis) and no bone submitted from area of suspected OM.
Complete evaluation was subclassified into OM found/not found microscopically.
Results:
Of 67 specimens with suspected OM, 25 (37.3%) were completely evaluated and 42 (62.7%) were incompletely evaluated for OM. Of the completely evaluated specimens, OM was microscopically confirmed in 22 cases (88%). The remaining 3 cases (12%) showed no microscopic OM. Of the specimens incompletely evaluated for OM, bone was not submitted from the area of suspected OM in 31 cases (73.8%), and bone was submitted but results were not reported in 11 cases (26.2%).
Conclusions: OM was diagnosed in only 22/67 (32.8%) cases of suspected OM over 5 years, due to inadequate sampling/evaluation of lower extremity amputation specimens. Our results suggest inadequate grossing of lower extremity specimens. Bone should be submitted from every lower extremity specimen with clinical or radiologic suspicion for OM, and we should not rely on the requisition form alone to identify suspicion for OM. By identifying this deficiency in our practice, we can educate all resident and attending pathologists and improve our evaluation of lower extremity amputation specimens. 
Conclusions:
Comparing the frozen section to final diagnosis, the current year did not show a significant increase in discrepancies or in major patient harm even though subspecialty surgical pathologists were faced with a variety of general intraoperative specimens. However, most of the senior attendings had trained and practiced in a generalized surgical pathology setting, which may skew the findings. Somewhat interestingly, the subspecialization seemed to foster an environment of collaboration and consultation among the various experts the department. Still, it is critical for surgical pathologists-in-training to retain a broad general surgical knowledge base. Background: Papillary lesions of the breast presenting with mammographic abnormalities or nipple discharge can be diagnosed as benign, atypical or malignant on core needle biopsies (CNB). Subsequent treatment algorithms can range from routine screening to surgical excision resulting in significantly differing healthcare costs. In this study, we present a cost-effectiveness analysis that determines the value of immunohistochemistry (IHC) aided definitive diagnosis using CK5/6 and p63 on downstream management of breast papillary lesions. Design: The surgical pathology database, at our institution, was queried for papillary lesions of the breast. Cases queried spanned a five year period with a minimum of 3 years follow up (n = 140). Morphology, p63 and CK5/6 IHC status was reviewed. Cost analysis using fiscal year (FY) 2015 CPT codes was performed after reviewing clinical history and treatment. Results: Of the 140 cases evaluated, 115 were diagnosed as benign on biopsy whereas 25 were diagnosed as atypical or malignant. 107 patients underwent surgical excision and 63 cases were diagnosed benign on both the NCB and excision. 19 cases were diagnosed as atypical on excision, previously diagnosed as benign on CNB. CK5/6 and p63 staining of the 19 benign NCBs identified 17 as atypical. IHC also identified all atypical lesions diagnosed by morphology alone (n=22). The sensitivity of using IHC, in addition to morphologic analysis, for a resection confirmed diagnosis was 95% versus 54%. Analysis of applicable FY2015 CPT coding shows the cost of biopsy with follow up surgical excision is $2047.65 per case. Performing IHC on the initial CNB would cost $416.48 per case. The total cost of the 107 cases that had both biopsy and follow up surgery is $219,098.55. When IHC staining was used, the cost of 107 biopsies is $44,563.36. However, the savings for benign lesions not requiring surgery is $115,567.40.
Impact of 2013 ASCO/CAP Guideline Recommendations on HER2 FISH Testing in Breast Cancer
Conclusions:
The high sensitivity and specificity of p63 and CK5/6 IHC staining in papillomatous lesions of the breast, resulting in reliable differentiation of benign from atypical lesions, should lead to more cost effective treatment algorithms sparing unnecessary surgery. This analysis is conservative and further analysis including cost of complications and morbidity are being performed. The analysis may be further refined after additional screening costs resulting from the five-fold increased risk of malignancy in patients with these lesions are included. 
An iOS App to Expedite the Evaluation of Immunohistochemistry Stains
Wilfrido Mojica, Gregg Mojica. University at Buffalo, Buffalo, NY; Gradology, Inc, San Francisco, CA. Background: Using tumor tissue to serve as control material for some antibodies is not possible based on the low frequency of some types of tumors and/or their dedication for use in research studies (e.g., mesothelioma for the calretinin antibody). Alternative tissues received at a greater frequency can then be used, provided it is made clear what cell type and cellular part(s) are expected to be stained (e.g., cytoplasmic and nuclear staining of peripheral nerves (ganglion cells and axons) in the appendix for the calretinin antibody). When this strategy is applied to numerous antibodies, recalling the expected staining pattern for every antibody may be difficult. As a means to help pathologists and technicians in our institution, a reference manual was initially created that delineated the expected staining patterns of the control tissues for each antibody, replete with images. Despite the presence of this tool, it soon became apparent that an alternative approach for the delivery of this information was necessary, one more mobile, less cumbersome and easier to navigate. An Apple-based Operating System (iOS) application was created to meet these new demands. Design: Photomicrographs of control tissue used for each antibody were taken and embedded with explanatory text for each antibody. The data was then imported to a mongo db database powered by a Node.JS backend. A client side iOS application was then written in the new Swift 2.0 programming language. This app then downloads and manipulates the database's information in the appropriate format for either iPads or iPhones.
Results:
The iOS app reduces the process of navigating antibody data in relation to control tissues to the movement or tap of a finger. Space is economized and mobility enhanced. Images can be easily expanded for further detail in the app when compared to the static nature in the traditional word or pdf format. Inclusion of new antibodies can be added to the database without the need to reprint an entire new volume. Links automatically take the viewer to the referenced item, not just the address.
Conclusions:
The iOS format can be customized to fit the needs of any immunohistochemistry laboratory. The availability of reference data in this format simplifies the everyday quality control evaluation of each antibody and promotes accurate and reproducible assessment by participating pathologists. An android version may be needed to be developed in the future. to isolate RNA for study of the subset of T lymphocytes found in areas of regression (RATs) from T lymphocytes found in areas of progressing tumor (TIL). Design: Patient samples were collected and immediately frozen using precaution to limit the exposure of RNAses. Prior to LCM, 5-mm-thick frozen tissue sections were placed on uncharged glass slides. Samples were either left unstained or stained with a standard H&E protocol. LCM was performed immediately after slide preparation.
Comparing H&E Stained and Unstained Slides of Frozen Tissue for Quality and Quantity of mRNA after Laser Capture Microdissection in Human Tissue for the Evaluation of the Microenvironment in Regressing and Progressing Primary Cutaneous Melanoma
Lymphocytes from the areas of regression, areas of progression, or non-specific inflammation were selected. RNA isolation was immediately performed after LCM.
The quantity and quality (260/280 ratio) of the RNA was evaluated for stained slides compared to unstained slides. Results: Overall RNA obtained from unstained slides was of equal quality compared to RNA from stained slides (Stained = 1.55, Unstained = 1.54). The overall quantity of RNA when compared to the stained slides (0.500 ug = median unstained, 0.432 ug = median stained) was more. Comparing the quantity and the quality of RNA did not yield significant results.
Conclusions:
Although there was no significant differences in the median quantity and quality likely due to the limited sample size, we feel the comparable RNA quality and the small increase in RNA quantity might be technically useful. The unstained slides did not hinder LCM extraction, and thus these results allow us to remove H&E staining from our methods. Less preparation results in less opportunity for RNA degradation. In addition, we plan to amplify the RNA in order to make quantity hurdles more surmountable. Pathologists assessed a discordant case as non-inferior if it would not affect a clinical decision. ER, PR, and Ki-67 were non-inferior if AT2 assigned a score near the breakpoint resulting in more intensive review. Her2 cases negative or positive by ACIS but equivocal by AT2 were non-inferior, as these reflex to FISH. Two equivocal cases by AT2, positive by ACIS were judged non-inferior due to concordance by FISH. 
Concordance after Pathologist Review
Conclusions:
The ACIS and AT2 quantitation algorithms for ER, PR, Her2, and Ki-67 produce similar results when the same regions of interest are analyzed. Using our computer assisted quantitation methodology, the AT2 is not inferior to the ACIS platform. There is currently no standardization of FF and CIT for nucleic acid extraction used for other molecular testing. The purpose of the study is to identify and standardize the optimal FF time and CIT for molecular testing, especially for small specimens or biopsies in our laboratory. Design: Sections of normal colon from resection were divided into five equivalent pieces (2.0 mm each), all of which had a cold ischemic time of 1 hour (based on the current recommendation for ERBB2 by FISH). The duration of formalin fixation was varied for each piece as follows: 6, 24, 48, 72 and 96 hours. The samples were processed using routine processor (Tissue-Tek VIP, Sakura). One H&E and 8 unstained 10 micron slides per tissue sample were used for DNA isolation using the EZ1 DNA Tissue Kit and the EZ1 Advanced XL DNA Paraffin Section Card, using a fixed elution volume of 50 µL. Amplifiable double stranded DNA (dsDNA) yield was estimated for each sample by measuring the dsDNA concentration obtained with the Qubit TM 2.0 fluorometer. Results: There is a significant inverse correlation between the dsDNA concentration and fixation time (Pearson's r = -0.977, p = 0.0042), where the dsDNA concentration progressively decreased from over 4.0 ng/ul (6 hour fixation) to 1.7 ng/ul (48 hours of fixation) and lastly to 0.4 ng/ul (96 hour fixation), representing a reduction of over 10-fold in dsDNA yield.
The Effect of Prolonged Duration of Formalin
Conclusions:
Prolonged FF significantly reduces dsDNA yield. In our laboratory, while the dsDNA yield at 6 hours FF is optimal, we determined that 24 hour fixation is very good and practical for our workflow. Future studies to evaluate the impact of cold ischemic time are ongoing. Validation and standardization of the FF and CIT should ideally be performed byeach laboratory Background: The evaluation of cerebrospinal fluid (CSF) for lymphoblastic leukemia/ lymphoma (ALL) patients is often rendered by a combination of diagnostic modalities, such as cytology and flow cytometry (FC). Prior studies have noted that FC is superior to cytopathologic examination in the diagnosis of hematologic malignancies. Hence, we evaluated the diagnostic utility and concordance of FC with CSF cytopathology in ALL. Design: We searched our departmental database for the past 15 years to identify cases of ALL where concurrent CSF FC and cytopathologic examination was performed.
Results: A total of 174 ALL cases were initially reviewed (age range: <1 up to 87 years, 113 children and 61 adults; M:F ratio of 1.7:1) of which 52 patients (30%) [41 (79%) B-ALL and 11 (21%) T-ALL] had concurrent FC and cytopathologic examination of CSF specimens. A total of 131 CSF specimens from these patients were analyzed (specimen range: 1-10 per patient, average:2). The diagnoses were categorized as positive, negative or inconclusive. Ninety four of 131 cases (72%) showed concordance between FC and cytopathology with 80 (85%) being negative by both FC and cytopathology, 13 of 94 (14%) positive by both, and 1 (1%) inconclusive by both modalities. Twenty four of 131 cases (18%) showed discrepant results with 8 of 24 (33%) showing a positive result by FC and negative (3) or inconclusive (5) by cytology. No positive cytology case was negative by FC.Twelve of 24 cases (50%) represented negative FC results with inconclusive cytopathology results and 4 of 24 cases (17%) represented inconclusive results by FC and negative cytopathology. Thirteen of 131 cases (10%) had insufficient material for FC due to low cellularity and 2 (15%) of these cases were suspicious for blasts by cytopathology.
Our findings indicate that the diagnostic yield of FC is superior to cytomorphologic examination; however, given the inherent low cellularity of CSF samples, adjunct cytopathology should be routinely performed for maximal diagnostic yield. Discrepant cases could be further analyzed by molecular methods to assess CSF involvement by ALL. TAT is calculated as the interval between specimen accessioning and signout (analytic phase) and for routine cases, many labs achieve the CAP recommended TAT of 2 days. Patients experience a longer total TAT which includes pre-analytic and post-analytic testing phases. While pre-analytic variables such as courier delays are well known, post-analytic variables have not been carefully studied. It is assumed that the advent of computerized reporting, immediate delivery of pathology results to electronic medical records (EMR), and wide use of patient access portals (PAP) enables patients to receive their results expeditiously. At our institution, surgical pathology results are transmitted to the EMR 1 hour after signout. Results are provided to patients by phone or release to a PAP either actively by the clinician after result review or automatically in 3 days without clinician review. In this study, we measure relative contribution of each testing phase to the total TAT and evaluate the effectiveness of computerized reporting in patient result delivery. Design: 151 consectuive outpatient biopsies over a 3 week period were tracked. Time of specimen collection, accessioning, and signout were derived from PowerPath. Time of physician result review, time of result release to the PAP or time results were communicated to the patient were extracted from the EMR (Epic). The time interval for each step was calculated and the relative contribution of each testing phase to the total TAT was assessed.
Results:
The average TAT for each component of the TAT is illustrated in Table 1 . The relative contribution of each component to the TAT is illustrated in Figure 1 .
Components of
Conclusions:
After careful assessment, the post-analytic phase consumes a remarkable 41% of total TAT, 76% of which is due to delay of clinician review after specimen signout. Despite rapid electronic report delivery at signout, results are often not expeditiously reviewed and communicated to patient.
Single Versus Multiple Levels for Routine
Background: A number of step-sections (levels) are usually prepared for small endometrial biopsy specimens. The number of initial levels can vary arbitrarily from one to three in different pathology departments. At Trillium Health Partners, three levels are evaluated from each endometrial biopsy tissue block. The purpose of this study was to evaluate whether assessment of only the second level would be sufficient for diagnosis, and therefore first and third levels are not necessary. Design: Endometrial biopsy and or curetting cases accessioned between January 1, 2015 and June 30, 2015 were retrieved from the Department of Anatomical Pathology at Trillium Health Partners Credit Valley Site. 320 cases with three levels were retrospectively reviewed. Level 2 of each of the 320 endometrial biopsy cases was reviewed to assess for adequacy of diagnostic material and necessity for reviewing levels 1 and 3. Results: After reviewing level 2, the diagnosis was rendered in 317 cases (99.06%). Three cases (0.94%) required assessment of additional slides. One case showed absence of endometrial tissue on level 2 and a few atrophic glands were present on level 1. Another case showed endometrial stroma only on level 2 and a few atrophic glands on level 3. The third case showed few atypical glands on level 2 suggestive for atypical hyperplasia. Level 3 showed unequivocal atypical hyperplasia. This last case was the only case where the original pathologist requested additional levels (4-6).
Conclusions: Assessment of a single slide per block (originally designated as level 2) is sufficient for assessment of endometrial biopsies. Preparation of three levels is not necessary; after evaluation of a single slide additional level can be ordered if necessary. This approach will save time for both professional and technical staff and reduce costs of slide storage.
Use of Barcode Tracking in Routine Histology Processing Significantly Decreases Pre-Analytical Errors
Mahboubeh Rahmani, Kristi Bedrossian, Elizabeth Genega. Tufts Medical Center, Tufts University School of Medicine, Boston, MA. Background: Given the manual nature of processing, surgical pathology case components including requisitions, specimen containers, cassettes and slides are susceptible to mislabeling. Continuous monitoring of the rate of mislabeled cases is useful to detect the causes of such mislabeling, understand the consequences of mislabeled specimens, implement safer practice, and help to fulfill the Joint Commission National Patient Safety Goal to identify patients and specimens correctly. We monitored mislabeled components of cases pre and post implementation of Cerner CoPath Advanced Barcode and Tracking (AB&T). Design: Mislabeled case components were reported by technical and professional staff using a confidential QA form beginning 01/2015. Follow up and correction of the errors were documented and the cause for each error was tracked. During the third quarter of 2015, AB&T was implemented at all aspects of specimen processing with emphasis on grossing and histologic processing. Technical and professional staffs were educated on the proper use of the system. Results: Table 1 shows the number/percentage of mislabeled blocks and slides. The percentage of mislabeled slides in the third quarter in comparison to the first and second quarters was decreased 12 and 10 times, respectively (from 0.7% in the first quarter and 0.6% in the second quarter to 0.06% in the third quarter). The first and second quarters had 0.19% and 0.07% mislabeled blocks respectively; the percentage of mislabeled blocks in the third quarter was the same as the second quarter after the initial phase of AB&T implementation. The third quarter showed a significant decrease in mislabeled slides. The origin of most block labeling errors are either pre-accessioning (in clinic) or at accessioning, both of which are not included in the scope of the AB&T system. Conclusions: Proper application of a barcode tracking system like AB&T at the various stages of routine processing of surgical pathology specimens significantly enhanced accuracy of patient identification by decreasing labeling errors. Our study confirms the impact of applying barcode tracking systems in decreasing pre-analytical errors and improving patient care.
Quantifying Protein Levels in Cells by Violin Plots: A Facile, Readily Visualized Method
Nicholas P Reder, Jonathan C Henriksen, Lawrence True. University of Washington, Seattle, WA. Background: The intensity of immunohistochemical stains of antigens in tumor cells is a metric for protein levels. Expression levels of proteins such as estrogen receptor and her2 guide therapy. By convention immunostains are visually scored. However, visual interpretation of immunohistologic stains is subject to observer variability. We developed data visualization and analysis methods that assess immunostain intensity independent of the pathologist's visual assessment. Design: Sections of tissue microarrays of cell lines expressing different levels of androgen receptor (AR) full length, AR variant 7, and AR variant 567 were stained with antibodies to C-terminal AR (Spring SP 242; absent in AR variants). Slides were digitized on a whole slide scanner. Using a Nuclear Algorithm, nuclei were segmented using thresholds. The number of nuclei at each gray level (0 -255) in the DAB color channel were then tabulated for each cell line quadruplicate. Background: At our tertiary academic medical center, gastrointestinal (GI) biopsies constitute 31% of total 61,428 surgical pathology specimens and 58% of biopsies accessioned yearly. Historically, the histology sectioning protocol of such biopsies involved the prospective production of unstained slides as intervening levels between H&E sections, of which <10% were being utilized. In an effort to improve utilization of laboratory resources, this practice was discontinued based on consensus among GI pathologists that it would be unlikely to impact patient care in a negative manner. The goal of this study was to retrospectively evaluate the financial impact of this protocol change and its effect on quality. Design: Total number of slides cut, unstained section utilization rates and turnaround times (TAT) for GI biopsies were compared 6 months before and 6 months after implementation of the protocol change. The material and labor costs were calculated, and both pathologists and histotechnologists were also surveyed to further determine the impact of the protocol change.
Results: A total of 271,262 slides were generated by the histology lab prior to implementation, including 36,319 (12.3%) unstained interval sections, versus 221,261 and, 16,939 (7.7%) after implementation, respectively (P<.0001). Unstained section utilization rates were 14.6% before, vs. 20.9% after implementation (P<.0001). There was with no significant change in adult GI biopsy TAT.
The estimated annualized monetary savings associated with the almost 20K reduction in unstained sections included $7000 in material costs and $100,000 in labor costs (based on 2.4 FTEs). 88% of the pathologists surveyed had no negative feedback in reference to both the quality of slides & the overall TAT , including complex cases that require ancillary studies. 100% of histotechnologists surveyed reported a significant increase in job satisfaction and significantly positive impact on workflow, including an approximately 40% reduction in total time e.g. leveling paraffin blocks, cutting and labeling unstained sections,due to the protocol change. Conclusions: Elimination of cutting and saving unstained sections of GI biopsy specimens results in significantly better utilization of lab resources and increased histotechnologist job satisfaction, whilst maintaining TAT and quality of patient care. This is especially important given the changing healthcare environment. 
Results:
The overall success rate of NGS was 96%; the remaining 4% failed either at the DNA quantity or library preparation steps. DNA concentration had a great impact on NGS success with 99.6% (231/232) success with DNA concentration ≥ 2 ng/ul; 75% (9/12) success with 1.5-2 ng/ul; and 8% (1/12) success with concentration ≤ 1.5 ng/ul. Surgical specimens with large circled tumor (≥ 60mm 2 ) have a higher success rate (107/107;100%) than that of smaller circled tumor (<10 mm 2 ) (29/38; 76%), and cytology smears (6/8; 75%). Decalcified specimens processed with formic acid have 100% success rate (3/3); however block age did not a have significant effect on NGS success.
Conclusions:
In this study, we show that certain pre-analytical factors such as procedure type and circled tumor size should be taken into consideration when selecting tissues for comprehensive NGS panel using Ion Proton. These factors contributed to DNA yield and ultimately affect the final sequencing success. 2 in all cases. The percentage of tumor in relation to total number of nucleated cells was >25% overall, with a majority of cases (15/20) ranging 60-100%. All cases had less than 20% necrotic material, 19/20 had necrosis of 0-10%. 8 of 20 cases had pathogenic variants in the following genes: EGFR, BRAF, and KRAS. In the remaining cases, NGS was successfully performed but no pathogenic variant was identified. Conclusions: A tumor area of >0.20 mm 2 in conjunction with >25% tumor cells and <20% of necrotic material can be used as positive selection parameters for specimens requiring molecular testing using targeted NGS in cell block material obtained by EBUS-FNA without need for any additional dissection procedure.
Prospective Quality Assurance of Breast Core Biopsies Minimizes Errors and Improves Patient Safety
Sejal S Shah, Natalie S Campbell, Gary L Keeney, Beiyun Chen, Daniel W Visscher. Mayo Clinic, Rochester, MN. Background: Quality assurance (QA) procedures are not well developed to evaluate the diagnostic accuracy of breast core needle biopsies (CNB). The aim of this study was to assess the inter-observer variability and disagreement rate for breast CNB among pathologists. Design: All breast CNBs, during a fifteen month period, that were not seen by at least 2 breast pathologists were blinded and reviewed for QA by a breast pathologist. QA was performed before the case was signed out and within 24 hours of initial review. Disagreements were classified as major or minor as determined by the impact on patient management. Opinions on cases of major disagreement were obtained from additional breast pathologists by blinded review followed by case discussion. Clinical and surgical follow up was recorded for all cases. Results: Of the total 2236 breast CNB, 1475 cases (66%) were submitted for QA. After initial QA and consensus review, 1403 cases (95%) were in agreement with the primary pathologist, 15 cases (1%) had minor disagreement and 57 cases (4%) had major disagreement. Majority of the cases (75%) with inter-observer variability and major disagreement were related to the presence or absence of atypia. In our analysis 37% of the major disagreement cases and 1.4% of total cases submitted for QA had significant impact on patient management. This is the first study to measure clinical significance of diagnostic discordance in breast CNB in a real time, clinical practice setting.
Histologic Evaluation of the Effects of Tissue Decalcification on the Immunohistochemical Markers in Bone Marrow Specimen
Marianna Shvartsbeyn, Mohamed E Salama, Rajan Dewar. New York University, New York, NY; University of Utah, Salt Lake City, UT; University of Michigan, Ann Arbor, MI. Background: The performance characteristics of each assay performed in the clinical immunohistochemistry laboratory must be appropriately validated before it is applied for clinical use. Recently published expert consensus recommendation on the decalcified material is to test a selected set of commonly ordered markers and to correlate the results with the routinely processed (control) tissues and ancillary test results, if available. We sought to evaluate the effect of decalcification on the immunoperoxidase expression in the tonsillar tissue, which has not been previously studied. We utilized digital imaging to quantify the staining intensity for each of the marker studied on the tonsillar tissue. By extension, we tested this approach as a practical method to validate immunostains in BM biopsy specimens. Design: A select panel of eleven IHC markers most commonly utilized for evaluation of bone marrow core biopsies was studied on a decalcified tonsillar tissue and was tested in parallel with the routinely processed section. Several bone marrow core biopsies were retrieved from the archives and reviewed retrospectively for comparative analysis. Results: We observed that different antigens showed different sensitivity to the same decalcification regimen; it is plausible that antigenic epitopes have different vulnerability to different decalcifying agents. The intensity of staining was significantly decreased in eight out of eleven immunoperoxidase stains evaluated. When the staining intensity was compared between the decalcified section and the tissue control in bone marrow specimens, Ki-67 was markedly decreased, CD34 and CD117 did not show any appreciable change in the staining quality or intensity, and all other immnomarkers were affected to various degrees. By objective image analysis performed on tonsil only, CD10, CD34 and MPO were not significantly affected. Conclusions: Decalcification may substantially alter the intensity of the IHC stains. This study exemplifies a practical and useful approach that could be employed to validate the immunostains in demineralized tissue for accreditation purposes, quality assurance and quality improvement.
Design: Cases submitted to the Irish National QI Programme over a 16 month period (January 2014 -April 2015) were identified using the National Quality Assurance Intelligence System (NQAIS), a novel information technology system designed to generate national quality pathology metrics. Cases coded as containing an amended report and IDC review were extracted and the data was analysed using SPSS with a Pearson Chi Square test to assess significance of association.
Results: A total of 537,590 histology and cytology cases were submitted by 33 laboratories to the NQAIS over 16 months with 31,925 subjected to IDC (mean = 5.9%). The total number of amended reports was 525 (mean = 0.097%) with 405 (77%) not subjected to IDC. The amended report rate for cases subjected to IDC was 0.037%, a significant reduction when compared to cases not subjected to IDC (p value = 0.022).
Conclusions:
Intradepartmental consultation is effective in reducing the number of amended reports even when the rate of review is below the recommended standard of 10%. However despite prospective review interpretive errors still occur and other forms of peer review including targeted retrospective review and multidisciplinary team / tumour board meetings are needed to further reduce the rate of amended reports. The QI Programme has published guidelines setting out key quality indicators including communication of reports to clinicians. We sought to quantify and evaluate the use of this parameter. Review of the national data over a 16-month period was carried out along with audit of the use of a specific Q code (Q23) in 4 centres enrolled in the QI programme with emphasis on specimen type, diagnosis and reason for communication.
Communication with Clinicians in Anatomical Pathology
Results: Over a 16-month period (January 2014 -April 2015) 9453 of 537590 cases (1.8%) were coded as Q23 (range 1.5 -2.1%). Non-designated cancer centres communicated with clinicians more often (2%, range 0.6-13.5%) than designated cancer centres (1.6%, range 0.6-2.7%). Data from the 4 centres audited showed the most frequent reasons for communicating with clinicians were urgent specimens 28%, malignant diagnoses 13.7%, unsuspected diagnoses 7.5% and clinician request 7.5%. The specific reasons stated for communication with clinicians from the 4 centres audited were as follows; North Shore -LIJ Health System, Lake Success, NY. Background: A validated and objective method to quantify Pathology Assistants (PA) productivity does not exist. Standardized relative value units based on complexity of diagnosis are commonly used for measuring Pathologists' productivity. However this method is not suitable for measuring PA productivity as it does not account for specimen complexity and workload. We describe a rigorous method to calculate the standardized relative value unit of work-effort (wRVU) required to dissect any pathology specimen. Design: We collected data on processing times for 11,933 specimens over a 4 month period (6/30/14-10/30/14) at our 2 tertiary academic medical centers. This included 158 pathology specimen descriptors encompassing CPT codes 88300 to 88309. Processing times were converted into a wRVU by dividing by 420 (minutes in a 7 hour working day). A priori we divided all the CPT descriptors into 5 distinct categories based on the time taken to dissect a specimen. The data were log transformed to obtain normal distributions. For all CPT descriptors the weighted geometric mean wRVU, standard error and 95% confidence intervals were calculated.
Results: There was a significant difference in the geometric mean wRVU by level (p<0.0001). There was no disagreement between the levels assigned a priori and the levels based on calculated mean wRVU, suggesting that our categorization based on total time for dissection is both practical and objective. 
Conclusions:
We propose an objective and quantitative method to measure PA productivity which accounts for specimen complexity. This tool facilitates the comparison of practical capacity to previously undefined theoretical capacity. We now have the ability to measure productivity of the PA workforce and track performance improvement efforts to remove inefficiencies in the production process.
Evaluation of Repeated Biomarker Testing In a Breast Consultation Service: One Institution Experience
Elena Vrotsos, Cesar A Llanos. University of Miami, Miami, FL. Background: Detailed attention to test utilization by Medicare and other payers as a way to curb health care cost is on the rise. This could translate in decreased reimbursements in a field where test pricing is already on the fall. At our institution, we routinely repeat receptor studies on all consult cases. In this study we evaluated the concordance of repeated tests and proposed more clinically significant and cost-beneficial approach.
Design: We performed an exploratory retrospective review of 100 neoplastic breast consult cases. We studied the percentage of concordance of the initial ER, PR and HER-2 testing with our repeated "in house" tests results, evaluated the medical necessity of these repeated tests and analyzed the possible clinical impact of discordant results. Results: Out of the 100 cases, 91 were invasive carcinoma and 9 carcinoma in situ (DCIS). The concordance rate was 100% and 89% for ER and PR respectively in the DCIS group. In the invasive carcinoma group there was 96.7% and 95.6% concordance rate for ER and for PR respectively. However, Her-2 concordance rate was 78%. Twenty cases were discordant for Her-2. Out of the twenty cases 6 cases had a major discordance with clinical significance (positive to negative or vice versa). In the six discordant cases, two cases were negative by IHC in the outside institution and positive in our institution with conformation by FISH. The other four major discordant cases were called positive by IHC outside, and were negative by IHC and FISH in our institution. Background: Every specimen submitted for pathological analysis is accompanied by a laboratory requisition form (LRF). Despite the fact that this LRF is often the only documentation provided to the pathologist, many lack critical information. As part of an initiative to enhance patient safety, we sought to identify deficiencies in the current LRF and devise a new LRF to improve communication between clinicians and pathologists. Design: The Anatomical Pathology database was searched for all cases accessioned in 2014. Mandatory fields in our LRF were assessed including: specimen site, collection time and date, most responsible physician (MRP), physician signature, and clinical history. In 100 consecutive finalized cases the 'clinical history' provided was reviewed and compared with the patient's electronic medical record for completeness and accuracy. A revised LRF was drafted to address deficiencies identified in the audit. Results: 51,722 cases were accessioned: 273 (0.5%) were missing anatomical site/ laterality, 739 (1.4%) were missing the collection date and time, and 6031 (12%) did not include a clinical history. Of the 100 LRF reviewed, only 25% included all mandatory information; fifteen requisitions did not include any clinical information and in 18 cases the history was incomplete. After 6 months in circulation, there was a significant increase in the percentage of LRF that included all mandatory data (71% vs 25%; p<0.001) although 15% were still lacking any clinical information. Conclusions: Very few LRF are submitted complete. Collaborating with our clinical colleagues, we drafted a new LRF which made it easier to communicate critical information including time in formalin and key aspects of the clinical history. However, in an academic center with high turnover of trainees and staff, constant communication and education is critical to ensure a properly completed LRF.
Conclusions
Utility of Routine Histopathological Analysis Following Orthopaedic Procedures for Benign Indications
Anna-Sophie Weidner, Francesca Khani, Theresa Scognamiglio. Weill Cornell Medical College, New York, NY. Background: At many institutions, it is standard practice to histologically assess the products of all orthopaedic procedures, even those performed for benign indications such as hallux abducto valgus deformity (bunion) and meniscal tear. To our knowledge, the frequency of clinically significant findings in these specimens has not been reported. Design: We reviewed the reports of 441 consecutive bunionectomy and 68 meniscectomy cases performed between July 2005 and July 2015 through a search of our pathology database. Clinical information was obtained through the electronic medical record. Any abnormal histopathological findings were correlated with the clinical impression. We assessed the approximate annual billing charges associated with the processing and evaluation of these specimens. Results: No occult malignancy was detected in any bunion or meniscal resection specimen. Benign lesions identified in bunionectomy cases included neuroma (4/441), ganglion cyst (6/441), synovial cyst (1/441), dematofibroma (1/441), and lentigo (1/441) and in meniscectomy cases included ganglion cyst (1/68); in all cases, the presence of an abnormal finding was clinically apparent and communicated to the pathology department. In 2 bunionectomy specimens and 1 meniscectomy specimen, crystalline deposits consistent with gout or pseudogout were identified, and synovial osteochondromatosis was present in 1 bunion resection; it is unknown whether these represent unexpected findings as the clinical information was unavailable for review. The approximate billing charges for bunion and meniscus resections at our institution amounted to over $10,000 annually. Conclusions: Routine histopathological evaluation of bunionectomy and meniscal resection specimens is unnecessary in the absence of clinically apparent abnormal findings. Elimination of this practice would be cost effective.
